NUTRACEUTICALS AND HERBALS AS ADJUVANTS IN THE CHEMOTHERAPY OF CANCER? A REVIEW by PHILIPS NATHALA, JOHN MANI et al.
Vol 8, Issue 2, 2020 ISSN -  2321-4406 
JOHN MANI PHILIPS NATHALA1, SHIVASHREE S1, SAHYADRI M1, MANJULA SN1*, VIPAN K PARIHAR2
1Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India. 
2Department of Radiation Oncology, University of California, Irvine, California, USA. Email: snmanjula@jssuni.edu.in
Received: 10 December 2019, Revised and Accepted: 20 January 2020
ABSTRACT
Cancer is the third leading cause of death worldwide. The current cancer treatments such as chemotherapy and radiotherapy resulting in the 
development of unintended adverse effects that reduce the quality of life and economic burden in oncology patients. Nutraceuticals along with food 
value have natural bioactive components that have reassuring therapeutic properties in several diseases. Herbs of significant interest have been 
proven to prevent and treat various types of cancer and also reduce the side effects of chemotherapy and radiotherapy. The efficacy of nutraceuticals 
and herbs such as chemopreventive and chemotherapy is highlighted. We conclude that further studies are required to countersign the targeted 
approaches and efficacy of herbs and nutraceuticals in cancer patients as adjuvant therapy.
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INTRODUCTION
The world’s third leading cause of death, especially in the middle-aged 
group inhabiting established realms. Compared to other fatal morbidity 
diseases, it is superior due to the revolution in routine, food customs, 
and treatment for significant disorders and diseases [1]. Such high 
death percentage climaxes the quandary of conventional chemotherapy 
and radiotherapy practiced in controlling this deadly disorder. These 
treatment regimens develop an increase in resistance, adding to the 
unadorned side effects of radiotherapy and chemotherapy; such 
treatment options additionally develop modern resistance of most 
cancerous cells toward the treatment [2].
Conversion of a normal cell into an invasive malignant phenotype 
necessitates tiers of initiation, development, and promotion through 
changing the unique genetic code. Although a single factor cannot reject 
the predisposition, people are at higher risk due to other additional 
factors, such as few high-risk cases, which may have a similar genetic 
context, nutritional, and dietary adoptions, which may determine the 
outcome of health [3].
Evolving revisions advocate that few plants originated intermediaries 
might influence molecular and cellular cascades of primary 
fundamental lump advance. However, some of these molecules may hurt 
traditional therapeutic standards. Numeral revisions by researchers 
steer onto herbals, anti-oxidants, unreal (synthetic) moieties to fix 
their corresponding characters in the supervision of countless forms 
of malignancy as adjuvants to chemotherapy and radiotherapy; 
meanwhile, assuming that they may advance the feat of malignancy 
treatment, though this view is debatable. Although this area is under 
exploration for over 40 years, even today there are still many qualms 
about their ultimate role.
CANCER STAND IN INDIA
“National Cancer Registry Program” is active since 1991 in reporting 
about the epidemiological subjects who are Indian inhabitants. The 
predictable cancer prevalence was a tad more in women. Certain types 
of cancer such as the esophageal, pharyngeal, stomach, lung, and oral 
cancers are more intricate in man, on the other hand, cervical and 
breast cancer stand at high incidence in females, followed by oral, 
gastric, and esophagus.
The intensifying figure of novel malignancy cases denotes the status 
of cancer exploration across India. The present research image ranges 
from basic studies required in governing the carcinogens to the 
research techniques to evaluate different molecular pathways and new 
drugs for treatment.
MOST NOTED ANTICANCER TREATMENTS WITH ADVERSE 
EFFECTS
The chemotherapeutic agents are well-recognized agents that are 
associated with severe adverse effects leading to the decreased 
quality of life and economic burden. In India, there are no extensive 
published data regarding the adverse effects of anticancer agents [4]. 
The cancer patients immensely suffered from adverse effects since 
chemotherapy regimens are highly complicated, and oncology patients 
are the inclined population with little tolerance [5]. The most common 
anticancer drugs causing adverse effects are imatinib, docetaxel, 
gemcitabine, paclitaxel, oxaliplatin, capecitabine, 5-fluorouracil, 
vincristine, 6-mercaptopurine, and gefitinib [6] which can cause 
cardiovascular toxicity, hepatotoxicity, neurotoxicity, nephrotoxicity 
gastrointestinal toxicity, and dermatological toxicity [7]. Radiation 
therapy can have specific or other side effects depending on which 
area of the body is being treated. Radiation to the brain can also have 
side effects that show up usually from 6 months to several years after 
treatment ends. Serious delayed effects can include memory loss, 
stroke-like symptoms, and poor brain function. Radiation to the breast 
can affect heart or lungs as well causing other side effects such as 
chemobrain, lymphedema, and some side effects of radiation therapy 
such as skin problems and fatigue can happen no matter at which part 
of the body is being treated [8].
NUTRACEUTICALS
Plentiful epidemiological, biological, and clinical revisions direct a 
stable connection among dietetic factors and lesser peril for developing 
malignancy. Dietary factors can prevent cancers, and they, on the other 
hand, can induce cancers [9]. The usual (natural) bioactive foods 
which deem to havee nutritional value and used in numerous ailments 
based on their beneficial effects are termed to be nutraceuticals. In 
trend cancer remedy approaches, which include chemotherapy and 
radiotherapy, induce unintended extra effects negotiating the lifetime 
of sufferers [10].
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A massive sum of revisions has confirmed that dietary routine stands 
as one of the top vital determining factors of enduring diseases such 
as diabetes, cardiovascular disorder, neurodegenerative diseases, and 
different types of malignancy [11]. such connotations between disease 
and the dietary habit displays that nutrition has a straight effect on 
healthiness. The increasing desire for longevity, growing urbanization, 
subsequent environmental changes, and lifestyle has made cancer a 
steadily growing health problem globally. Therefore, many research 
papers and surveys show the influence of environmental surroundings 
and food regimen on the cellular function and health of an individual.
Some nutritional dietary supplements protect the body from most 
cancers through cleansing, even as others resource in lowering the 
noxious effects of radiotherapy and chemotherapy. The unfavorable 
side effects related to chemotherapy aggravate the dietary issues, and 
the right amount of nutrient supplement must be a critical part of 
chemotherapy. Nutraceuticals save you from the side effects of both 
with the aid of intervening or editing the biologic response [12].
The primary belief of nutraceuticals was well-thought-out as organic 
foods to deliver strength and was advised daily for consumption within 
the body for well-being until the year 1990. For instance, quite a lot 
of food industries initiated to augment iodine in the table salt to avoid 
goiter during the early 19th century, which epitomizes the efforts on the 
way to making purposeful components [13].
In the new 21st century, the earlier concept of nutraceuticals as effective 
therapeutic supplements and their enormous budding awareness is 
shown, leading to the recognized idea of nutraceutical medicine as a 
new branch of “complementary and alternative medicine”. Around two 
millennia past, hippocrates, the father of western medicine, advised: 
“Let food be thy medicine and medicine be thy food” accentuating the 
affiliation among human health and nutrition, in actual it is among 
the precise vitamins for health and their healing paybacks. Plant food 
products can be defined as food supplements, functional foods, and 
nutraceuticals on the basis of the isolation step. Where unadulterated 
and purely extracted plant molecules are referred to as nutraceuticals, 
semi-purified plant products, which are not considered regular food, 
are referred to as functional food [14].
Foods that can be taken recurrently as a diet to uphold the overall 
health are termed to be food supplements. Plant food features many 
ingredients such as phytonutrients, polyunsaturated lipids, and 
secondary metabolites such as flavonoids, glucosinolates, lignans, 
phytosterols, polyphenols, phytoestrogens, phytates, and terpenes [15].
CURRENT SCENARIO
Since the ancient humankind, the extracts of herbals and natural 
materials are still under use for various purposes. At present, around 
470 nutraceutical and functional food products are available with 
documented health benefits. In the process of pharmaceutical 
development, clinical test results from animal tests and studies 
to ascertain the effects are legally required; for now, there is no 
documentation strategy for foods used to prevent diseases in the 
ancient era.
Nutraceuticals used for cancer usually are as follows:
•	 Soyfoods	 are	 a	 source	 of	 isoflavones	 that	 possess	 cancer	
chemopreventive properties.
•	 Lycopene	concentrates	on	 the	 testes,	 skin,	prostate,	 and	adrenal	
protecting against cancer.
•	 Saponins	possess	antitumor	and	antimutagenic	activity.
•	 Curcumin,	 a	 polyphenol	 of	 turmeric	 possess	 anticarcinogenic,	
antioxidative,	and	anti-inflammatory	properties	and	so	on.
•	 There	have	been	reports	of	anti-tumor	activity	 in	vegetables and 
fruits such as beetroots, cucumber fruits, and spinach leaves.
Coming to India’s nutraceutical scenario, poor eating habits and 
sedentary lifestyles have indeed led to an increase in the incidence 
of diet and health complications, although there is growing public 
awareness of the importance and value of proper nutrition and diet for 
good health and longevity.
It has been reported that many nutraceuticals are incredibly active 
and also have a profound effect on cell metabolism and sometimes 
have a little adverse effect. They have always been new and competed 
against India’s underdeveloped pharmaceutical industries. The 
French oncologist reported that high doses of nutrients were used in 
conjunction with conventional chemotherapy in patients with lung 
cancer, which reduced the recurrence of the tumor to half, which also 
reduced cytotoxic levels [16].
Vitamin C
It reduced the formation of nitrosamine in the intestinal tract, which 
reduced the incidence of stomach and esophageal cancers significantly. 
The survival time of people treated for terminal cancers has increased. 
Epidemiological studies appear to point to ascorbate as a possible 
chemopreventive for breast cancer. A Latin American study compared 
nutrient intake and dietary patterns of 748 cervical cancer patients 
with 1411 controls [17]. The results supported a protective effect 
of Vitamin C against invasive cervical cancer. An inverse relationship 
between Vitamin C status and risk for cervical dysplasia was observed. 
The relationships of dietary and supplemental factors with esophageal 
cancer were examined in 147 males with esophageal cancer and 
264 males with other diagnoses at Roswell Park Memorial Institute. 
Vitamins C, A, and intakes of fruits and vegetables were associated with 
decreased risks of esophageal cancer [18].
Fish oil
In hyperthermia and chemotherapy, eicosapentaenoic acid improved 
tumor inhibition by altering the cancer cell membranes, which 
increased vulnerability [19].
Selenium
A trace element is known for its antitumor genic effects. It is a powerful 
antioxidant found in enriched white rice, seafood, and whole wheat. 
Glutathione peroxidase, an antioxidant enzyme that protects against 
free radical damage, constitutes selenium. Increased risk of cancer is 
reported in the world’s soil which is deficient in selenium resulting in 
low selenium intake. People need very little selenium to protect their 
health [20].
Ginseng
Panax ginseng improves the use of mitomycin (anticancer and 
antibiotic) to increase the anticancer drug’s potency. Nutrition therapy 
enables medical therapy to make the most selective toxins (anticancer 
drugs) on the tumor cells [21].
Avemar™
Avemar is a formulated and “Approved dietary food for special medical 
purposes of cancer patients,” it is fermented wheat gram extract that is 
highly recommended into adjuvant protocols (supported by the clinical 
study) of high-risk skin cancer patients [22].
HERBALS
Herbal drugs include plants, plant mix, and green complexes. In 
allopathic and traditional medicine, herbal plants were used across 
the ecosphere in a variety of ways. Herbal medicines are recognized 
for their efficacy, affordability, convenience, and safety. Regardless 
of advancements in synthetic chemistry, approximately 80% of the 
ecosphere’s inhabitants still hang onto medicinal plants for the 
treatment of disease [23]. The biological activity of any plant is due to 
its components, i.e., phytochemicals, flavonoids, and phenols. They are 
plant-based constituents that directly arbitrate their positive health 
benefits by changing precise molecular objectives directly or indirectly 
as stabilized conjugates affecting metabolic cascades [24]. Natural 
anticancer products offer valuable means of increasing cancer treatment 
to a new level of success with less or no adverse side effects [25]. The 
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precise use of phytochemicals in this era of medicines may provide us 
with new dimensions in improving the outcome of chemotherapy. For 
the past 30 years, natural products, especially those from the plant 
kingdom, have been a vital source of chemotherapy [26]. “Cancer is 
hostile to the human body, and hostile environment is cancerous to 
plants” which means that the plants which can proliferate in multiple 
but diverse environments may naturally provide us with a vital source 
of anticancer agents [27].
Herbs are usually classified according to their behavior, herbs alter 
the immune system and chemoprotective herbs. Herbs that modify 
the immune system show a significant increase in cancer patient’s 
resistance [28]. Malignant cells subsequently decline the immune 
system’s potency by truncated immunogenicity in people with cancer. 
Most herbal medicines stimulate immunity and improve it [29] and also 
protect the bone marrow against chemotherapy’s myelosuppressive 
side effects. Herbal medicines prevent the progression of oncogenic 
apoptosis. Instance, the apoptosis in cancer cells is bought by curcumin, 
which blocks the NF-KB signaling pathway through the regulatory 
phosphorylation of the IKB enzyme [30].
HEALTH BENEFITS OF DIFFERENT HERBS AND HERBALS DURING 
CANCER
Ellagic acid
Ellagic acid is a polyphenol compound extant in many nuts, seeds, and 
fruits, such as black raspberries, pomegranates, walnuts, strawberries, 
raspberries, and almonds. In another study,  Baradaran et al. showed 
that ellagic acid has a chemoprotective effect due to strong antioxidant 
properties, which lead to reducing OS [31]. Some studies in the past 
also indicated that ellagic acid showed chemoprotective, anti-apoptotic, 
and anticarcinogenic properties that make it interesting for further 
studies in different disorders particularly cancer cell systems [32].
Vinca rosea (periwinkle)
Periwinkle, also called Catharanthus roseus, is the foremost 
antitumor herb. The components of this are vinca alkaloids such as 
vincristine (leurocristine), vinblastine, and reserpine. To display 
their anticancer property, it is essential for the alkaloids to bind with 
tubulin (microtubule protein), resulting in the halt of microtubules 
and constraint in the construction of spindles during the metaphase 
hence, halt the division of malignant cells [33]. Vinblastine is used 
in treating Hodgkin’s disease, a malignancy of kidney, and non-
Hodgkin’s lymphoma. Nevertheless, vincristine is prescribed with a 
combination of other anticancer agents for the effective treatment of 
various cancers such as lung, breast, cervix, and liver [34]. As of now, 
periwinkle’s herbal compounds were legalized by the FDA for treating 
the neoplasm. In general, vincristine has used the drug during breast 
cancer [33].
Limitations
It has aftereffects like a loss of the need to eat, bone ache, unhappiness, 
giddiness, constipation, intestinal pain, and hair loss [35].
Curcuma longa (turmeric)
Curcuma Longa confirms the full gamut of therapeutic effects. It is 
antitumor, anti-inflammatory,-antioxidant, antimutagenic, antifungal, 
antiviral, antibacterial, and hepatoprotective. Constituted curcumin 
averts the making of eicosanoid (injurious) like PGE-2, henceforth, 
hinders the cancer cell’s progress [36]. Curcuminoids extracted from 
turmeric like curcumin (Di-feruloyl-methane) suppressed cancer cells 
at each step, i.e., initiation, growth, and metastasis by hindering the 
malignant cell propagation in G2/S phase and inducing apoptosis. It also 
hinders angiogenesis, a rate-limiting step in the metastasis and growth 
of malignancy [37].
Limitations
1 g/day ingestion of turmeric till 9 months exerted substantial effects 
on the worsening of precancerous lesion of palatal malignancies. 
Although, after administering turmeric powder of dose up to 10 g/kg, 
no acute toxic signs are observed [38].
Nigella sativa (Kalonji or black cumin)
Known as Kalonji in South Asia used to promote health and 
fight diseases.  By tradition, it is used in the promotion of overall 
health conditions besides during a headache, cold, and microbial 
infections [39] and it also stimulates the immune system by increasing 
helper T cells (T4) to suppressor T cells (T8) ratio and literature also 
states that is also refined the natural killer cell activity by decreasing 
the immune globulin (IgA, IgM, and also IgG) levels [40].
Anticancer activity
N. sativa is immune-modulating, immune-potentiating, and acts like 
interferon. Ethanolic extract of N. sativa was found to inhibit cancer 
cell progression of endothelial cells in vitro [41]. Thymoquinone and 
di-thymoquinone, active constituents of N. sativa were found to have 
potent anticancer activity at odds with various cancers they have 
shown their strong cytotoxic actions even on the multidrug resilient 
humanoid tumors which were 10-fold more resistant to etoposide and 
doxorubicin [39]. MCF-7 breast cancer cell line in vitro was inactivated 
after the treatment with alcoholic extract or in combination with 
hydrogen peroxide. N. sativa terminates malignant cells by attaching 
Table 1: Health benefits of certain nutraceuticals and herbals during cancer treatment
Nutraceuticals/herbals Health benefits during cancer treatment
Vitamin C Chemoprotective in the treatment of esophageal and breast cancer
Fish oil Improved tumor inhibition by altering cancer cell membranes
Selenium Antitumor genetic effect
Ginseng Nutrition therapy enables anticancer drug’s (like mitomycin) potency
Avemar Dietary food for cancer patients specifically for high-risk skin cancer patients
Ellagic acid (found in many nuts and fruits such as black 
raspberry, pomegranates, walnuts, strawberries, and almond)
Chemoprotective, anti-apoptotic, anticarcinogenic
Vinca rosea Antitumor herb, effective in the treatment of lungs, breast, and cervix cancer
Curcuma longa Antitumor, anti-inflammatory, antioxidant, antimutagenic, antifungal, antiviral, 
antibacteria, and hepatoprotective
Nigella sativa Inhibit cancer cell proliferation, immune-modulating, and immune-potentiating
Cannabis (marijuana) Herb that relieves from pain, depression, nausea caused during chemotherapeutic 
treatment of cancer
Allium sativum Antiproliferative effects and act as anticancer for intestinal cancer chemotherapy
Carica papaya Anticancer activity
Ganoderma lucidum Anticancer agent due to its role as an activator of the immune system response
Mangifera indica Chemoprotective properties and as nutrition therapy enables anticancer drug’s potency
Solanum torvum Act as a natural antibiotic, antimicrobial, antibacterial, and hepatoprotective activity
Crateva magna Antitumor activity
Azadirachta indica Enables anticancer drug’s potency
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to the asialofetuin (lectin) superficially, instigating their clumping and 
aggregation [42].
Limitations of N. sativa
Acutely toxic once administered 25 g/kg orally. However, noxious 
indications appear once administered 25 g/kg intravenously [43].
Cannabis (marijuana)
Cannabis sativa is a magic herbal that relieves from pain, depression, 
and nausea caused during chemotherapeutic treatment of cancer. 
“Δ9-tetrahydrocannabinol	 (THC)”	 is	 the	 core	 integral	 moiety	 found	
in cannabis that is accountable for its pharmacological activity in the 
curative medicinal ground [44-47]. Researchers sign post the upsurge 
of weight gain and appetite after the ingestion of marijuana (cannabis) 
for AIDS-associated anorexia and cancer patients [45]. “Nabilone 
(Cesamet),” a synthetic derivative of THC, was active in governing 
chemotherapy brought vomiting and nausea [46]. Moreover, it is also 
effective in treating the children undergoing chemotherapy [47].
Limitations of cannabis
Although the side effects of cannabis are not every so often understood 
in the bodily facets, cognitive, or mental domain, like powerlessness to 
recognize the time interval and distant objects and memory thought 
manners [48].
Allium sativum (garlic)
The beneficial use of A. sativum for the treatment of cancer was first 
endorsed by the father of western medicine, i.e., Hippocrates. It 
has defensive possibilities and partakes in enhancing the immune 
system [49]. “Allicin, S-allyl cysteine, di-allyl-di-sulfide, and di-allyl-tri-
sulfide cristine” possess anticancer activity. It plays an important role 
in intestinal cancer chemotherapy. Metabolic by-products of organic-
sulfur constituents of garlic are responsible for its antiproliferative 
effects [50].
Carica papaya
C. papaya (fruitless type) extract inhibited the cell growth when tested 
against the MCF-7 cell line at different concentrations (25, 50, 100, 200, 
and 400 µg/ml). It exhibited exponential growth in inhibiting the cell 
growth on increasing the concentrations, the lowest growth inhibition 
being 9.38% at 25 µg/ml, and the highest growth inhibition was 71.76% 
at 400 µg/ml. The IC50 value was more than 233.01 µg/ml. This study 
reveals that C. papaya extract possesses anticancer activity[51].
Ganoderma lucidum
It has been a substantial source of natural mycological remedies 
for many years. Nevertheless, the usage of Ganoderma is poorly 
depicted in the field of cancer immunotherapy. Ganoderma’s beta-
glucan polysaccharide plays a significant role in immune surveillance 
and chemoprevention of cancer [52]. The most comprehensively 
investigated important pathways are NF-kB and MAPK. The broad-
spectrum application of Ganoderma enables us to use it for the 
treatment of cancer and immune disorders and as an adjunct to 
modern cancer therapies due to its is regulatory actions of the immune 
system [53]. Available evidence suggests that the efficacy of Ganoderma 
species as an anticancer agent due to its role as an activator of the 
immune system responses. Much literature is available about the other 
natural sources such as microorganisms and marine, which can be used 
as chemotherapeutic agents directly or indirectly [54].
Mangifera indica (Mango)
Mango pulp extract (MPE) and lupeol were evaluated for 
chemopreventive properties against 7, 12-dimethylbenz (a) anthracene 
induced alteration in the liver of Swiss albino mice. MPE was found to 
be effective in combating cellular injury of mouse liver by modulating 
cell-growth regulators which were induced through oxidative stress 
[55]. Prasad et al. reported that mangiferin increased the efficacy of 
doxorubicin in MCF-7 [56].
Solanum torvum Sw. (night berries)
Solanum torvum Sw. is a member of the family Solanaceae, and its 
fruits are commonly called night berries which are useful for treating 
liver and spleen enlargement, cough and also used as a hematopoietic, 
antimicrobial, and analgesic agent. The leaf extract has been reported 
to have antiviral and antiulcerogenic properties. The fruit coat 
exhibited significant antibacterial activity against pathogenic bacteria 
when compared to standard antibiotics and hence acted as a natural 
antibiotic. Recently, it has been reported that this fruit extract has 
hepatoprotective activity [57,58]; therefore, apparently this fruit 
extract can be used as adjuvant therapy for chemotherapy-induced 
hepatotoxicity.
Crateva magna
C. magna belongs to the family Capparaceae commonly used in the 
treatment of urinary disorders. Currently, in vivo and in vitro antitumor 
activity of leaves C. magna has been reported [59]. This study reveals 
that the ethanolic extract of C. magna has antitumor activity [60].
Azadirachta indica (neem)
Studies of extracts from all major parts of neem plant, including leaves, 
flowers, fruits, and seeds, have shown promising chemopreventive 
and therapeutic effects in pre-clinical research [61]. The underlying 
mechanisms of such anticancer effects of neem have begun to unravel 
with accumulating studies. As a natural resource, neem extract has the 
advantages of easy availability, low cost, and safety to humans, which 
collectively make neem-derived compounds valuable candidates for 
anticancer therapy [62]. Preclinical studies have primarily established 
neem as a potential preventive and therapeutic agent against various 
types of cancer [63].
Interestingly, neem has been shown to improve the efficacy of 
other anticancer drugs besides its anticancer functions as a single 
agent [64-66]. The combination of neem-derived gedunin and cisplatin 
further decreases the proliferation of treated ovarian cancer cells by 
almost 50% compared to the cells treated with only cisplatin [61]. The 
combination of a sub-lethal dose of ethanolic NLE and cisplatin also 
provides synergistic effects in decreasing the viability of breast and 
cervical cancer cells compared to individual compounds alone [67,68]. 
Further investigation is warranted to determine whether neem could 
sensitize cancer cells to the cytotoxic effects of other therapeutic 
regimens and whether combination therapy could offer potential 
clinical benefits.
ADJUVANT THERAPY – HOW IMPORTANT IS IT?
All the therapies to fight cancer are advanced into the age of specific 
molecular targets, yet the current therapies are inadequate because 
of the severe side effects of antitumorigenic agents and cell-signaling 
complexity. It is evident that a few types of cancers are resistant to 
conventional chemotherapeutic agents. Desired results with the least 
number of side effects have been obtained with adjuvant therapies 
that have also improved the quality of life. Although, it is associated 
with dose-relationships. Therefore, it is necessary for mechanistic and 
targeted approaches for improving the quality, efficacy, and minimizing 
unwanted effects, which is crucial during the chemotherapeutic 
treatment. Although, shortlisting the appropriate adjuvant will always 
be the rate-limiting step to achieve effective adjuvant synergism.
Over the past few years, many nutraceuticals and few dietary agents are 
deemed to imitate the actions of anticancer drugs, which can be used as 
adjuvants during chemotherapy refer Table 1. Few agents act through 
regulation of various cell signaling pathways which in turn changes the 
fate of biological systems. For the fact, many of such agents were proven 
to be nontoxic and synergistic when used along with the different 
classes of anticancer drugs. Therefore, it is evident that these agents 
can be combined with anticancer drugs which could be of profitable use 
in dealing with cancer and its side effects.
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CONCLUSION
The use of herbs and nutraceuticals is growing rapidly every day, 
but the molecular and mechanistic actions of respective classes from 
natural sources are still lacking profound clinical data. Therefore, there 
is a need for practices like adjuvant therapy in addition to conventional 
chemotherapy. Adjuvant therapy not only renders the effectiveness 
of conventional chemotherapy but also increases the quality of life 
of patients, for which awareness should be created among the public 
regarding the promising use of certain herbs and nutraceuticals as an 
adjuvant which might be helpful in the critical need of the hour.
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